Oppenheimer Asset Management Inc. Takeda Pharmaceutical CO LTD Transaction History

Oppenheimer Asset Management Inc.

$6.65 Billion
Q1 2024

A detailed history of Oppenheimer Asset Management Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 230,650 shares of TAK stock, worth $3.01 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

230,650

Previous 217,064 6.26%

Holding current value

$3.01 Million

Previous $3.1 Million 3.42%

% of portfolio

0.05%

Previous 0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$13.89 - $15.04 $188,709 - $204,333	13,586 Added 6.26%	230,650 $3.2 Million
Q4 2023 Feb 13, 2024	SELL	$13.36 - $15.43 $354,320 - $409,219	-26,521 Reduced 10.89%	217,064 $3.1 Million
Q3 2023 Nov 07, 2023	SELL	$15.03 - $16.32 $92,810 - $100,776	-6,175 Reduced 2.47%	243,585 $3.77 Million
Q2 2023 Aug 02, 2023	SELL	$15.57 - $17.11 $64,148 - $70,493	-4,120 Reduced 1.62%	249,760 $3.92 Million
Q1 2023 May 10, 2023	SELL	$15.28 - $16.48 $145,740 - $157,186	-9,538 Reduced 3.62%	253,880 $4.18 Million

Q4 2022 Feb 06, 2023	SELL	$12.42 - $15.62 $379,406 - $477,159	-30,548 Reduced 10.39%	263,418 $4.11 Million
Q3 2022 Nov 14, 2022	SELL	$12.8 - $28.65 $13,363 - $29,910	-1,044 Reduced 0.35%	293,966 $3.81 Million
Q2 2022 Aug 08, 2022	SELL	$13.12 - $15.03 $202,572 - $232,063	-15,440 Reduced 4.97%	295,010 $4.14 Million
Q1 2022 May 12, 2022	BUY	$13.54 - $15.35 $296,878 - $336,564	21,926 Added 7.6%	310,450 $4.45 Million
Q4 2021 Feb 02, 2022	SELL	$13.17 - $16.4 $1.74 Million - $2.16 Million	-131,993 Reduced 31.39%	288,524 $3.93 Million
Q3 2021 Nov 12, 2021	SELL	$16.3 - $17.26 $350,287 - $370,917	-21,490 Reduced 4.86%	420,517 $6.89 Million
Q2 2021 Aug 03, 2021	BUY	$16.55 - $18.64 $1.03 Million - $1.16 Million	62,104 Added 16.35%	442,007 $7.44 Million
Q1 2021 May 17, 2021	BUY	$16.71 - $19.9 $565,767 - $673,774	33,858 Added 9.78%	379,903 $6.94 Million
Q4 2020 Feb 11, 2021	BUY	$15.39 - $18.97 $389,397 - $479,978	25,302 Added 7.89%	346,045 $6.3 Million
Q3 2020 Nov 13, 2020	SELL	$17.1 - $19.19 $144,973 - $162,692	-8,478 Reduced 2.58%	320,743 $5.72 Million
Q2 2020 Aug 11, 2020	SELL	$14.59 - $19.5 $914,311 - $1.22 Million	-62,667 Reduced 15.99%	329,221 $5.9 Million
Q1 2020 May 08, 2020	SELL	$13.02 - $20.31 $454,580 - $709,103	-34,914 Reduced 8.18%	391,888 $5.95 Million
Q4 2019 Feb 07, 2020	SELL	$16.88 - $20.83 $321,513 - $396,749	-19,047 Reduced 4.27%	426,802 $8.42 Million
Q3 2019 Oct 31, 2019	BUY	$16.15 - $17.99 $126,373 - $140,771	7,825 Added 1.79%	445,849 $7.67 Million
Q2 2019 Aug 09, 2019	BUY	$16.58 - $20.49 $888,953 - $1.1 Million	53,616 Added 13.95%	438,024 $7.75 Million
Q1 2019 Apr 24, 2019	BUY	$16.7 - $21.52 $1.24 Million - $1.6 Million	74,247 Added 23.94%	384,408 $7.83 Million
Q4 2018 Jan 30, 2019	BUY	$15.64 - $21.1 $4.85 Million - $6.54 Million	310,161 New	310,161 $5.22 Million

Others Institutions Holding TAK

# of Institutions

341

Shares Held

76M

Call Options Held

1.85M

Put Options Held

121K

View Full List

About TAKEDA PHARMACEUTICAL CO LTD

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $40.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

More about TAK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.

Account

Oppenheimer Asset Management Inc. Takeda Pharmaceutical CO LTD Transaction History